Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fattorossi

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Journal of Neurology|February 28, 2007
Paraneoplastic diseases associated with thymomaAmelia Evoli, Giacomo Maria Minicuci, Roberta Vitaliani, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
Pharmacology & Toxicology|March 8, 2002
A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug developmentC Ferlini, M Distefano, L Pierelli, et al.
Clinical Immunology and Immunopathology|September 1, 1987
1,25-Dihydroxyvitamin D3 and phorbol esters (TPA) may induce select in vitro differentiation pathways in the HL60 promyelocytic cell lineP Rossi, L Chini, A Fattorossi, et al.
Immunology|November 25, 2003
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoireAlessandra Battaglia, Gabriella Ferrandina, Alessia Buzzonetti, et al.
Journal of Clinical Immunology|November 15, 2007
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapyAndrea Fattorossi, Alessandra Battaglia, Alexia Buzzonetti, et al.
Immunology|November 22, 2007
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Giovanni Monego, et al.
Immunology|January 3, 2013
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell developmentAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1988
Complement activation is variably affected by fibronectin preparations obtained through different proceduresA Fattorossi, S Le Moli, O Pontesilli, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Journal of Neurology|February 28, 2007
Paraneoplastic diseases associated with thymomaAmelia Evoli, Giacomo Maria Minicuci, Roberta Vitaliani, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
Pharmacology & Toxicology|March 8, 2002
A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug developmentC Ferlini, M Distefano, L Pierelli, et al.
Clinical Immunology and Immunopathology|September 1, 1987
1,25-Dihydroxyvitamin D3 and phorbol esters (TPA) may induce select in vitro differentiation pathways in the HL60 promyelocytic cell lineP Rossi, L Chini, A Fattorossi, et al.
Immunology|November 25, 2003
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoireAlessandra Battaglia, Gabriella Ferrandina, Alessia Buzzonetti, et al.
Journal of Clinical Immunology|November 15, 2007
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapyAndrea Fattorossi, Alessandra Battaglia, Alexia Buzzonetti, et al.
Immunology|November 22, 2007
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Giovanni Monego, et al.
Immunology|January 3, 2013
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell developmentAlessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancerAlessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1988
Complement activation is variably affected by fibronectin preparations obtained through different proceduresA Fattorossi, S Le Moli, O Pontesilli, et al.
Pageof 14